Haemophilus Infections (DBCOND0033285)

Identifiers

Synonyms

Haemophilus Infection / Haemophilus infections / Haemophilus infection NOS / Hemophilus infection / Haemophilus infection (disorder)

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT00802867	Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) Bordetella pertussis fimbriae 2/3 antigen Bordetella pertussis pertactin antigen Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)	prevention	4	completed
NCT00772928	Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) Bordetella pertussis fimbriae 2/3 antigen Bordetella pertussis pertactin antigen Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen Poliovirus type 1 antigen (formaldehyde inactivated) Poliovirus type 2 antigen (formaldehyde inactivated) Poliovirus type 3 antigen (formaldehyde inactivated) Streptococcus pneumoniae type 14 capsular polysaccharide diphtheria CRM197 protein conjugate antigen Streptococcus pneumoniae type 18C capsular polysaccharide diphtheria CRM197 protein conjugate antigen Streptococcus pneumoniae type 19F capsular polysaccharide diphtheria CRM197 protein conjugate antigen Streptococcus pneumoniae type 23F capsular polysaccharide diphtheria CRM197 protein conjugate antigen Streptococcus pneumoniae type 4 capsular polysaccharide diphtheria CRM197 protein conjugate antigen Streptococcus pneumoniae type 6B capsular polysaccharide diphtheria CRM197 protein conjugate antigen Streptococcus pneumoniae type 9V capsular polysaccharide diphtheria CRM197 protein conjugate antigen	prevention	3	completed
NCT00772369	Retrospective Survey of Safety of Fourth Dose Pentacel® in Children	No drug interventions	Not Available	Not Available	completed
NCT00255021	Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) Haemophilus influenzae b polysaccharide-tetanus conjugate Poliovirus type 1 antigen (formaldehyde inactivated) Poliovirus type 2 antigen (formaldehyde inactivated) Poliovirus type 3 antigen (formaldehyde inactivated)	prevention	4	completed
NCT00432042	Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035)	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) Bordetella pertussis pertactin antigen (formaldehyde inactivated) Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) Measles virus vaccine live attenuated Mumps virus strain B level jeryl lynn live antigen Rubella virus vaccine Varicella zoster vaccine (live/attenuated)	prevention	3	completed
NCT01357720	Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vaccination	No drug interventions	prevention	4	completed
NCT00343889	Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio Vaccine	Oral Polio Vaccine	prevention	3	completed
NCT00254969	Immunogenicity and Safety of Pentaxim in South African Infants	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) Haemophilus influenzae b polysaccharide-tetanus conjugate Poliovirus type 1 antigen (formaldehyde inactivated) Poliovirus type 2 antigen (formaldehyde inactivated) Poliovirus type 3 antigen (formaldehyde inactivated)	prevention	3	completed
NCT00855855	Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) Bordetella pertussis fimbriae 2/3 antigen Bordetella pertussis pertactin antigen Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen Hepatitis B Vaccine (Recombinant) Poliovirus type 1 antigen (formaldehyde inactivated) Poliovirus type 2 antigen (formaldehyde inactivated) Poliovirus type 3 antigen (formaldehyde inactivated)	Not Available	Not Available	completed
NCT00259337	Immunogenicity and Safety of Pentaxim™ in an Indian Population	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) Haemophilus influenzae b polysaccharide-tetanus conjugate Poliovirus type 1 antigen (formaldehyde inactivated) Poliovirus type 2 antigen (formaldehyde inactivated) Poliovirus type 3 antigen (formaldehyde inactivated)	prevention	3	completed
NCT00625118	A Study to Gather Safety Data Following Administration of a Hib-containing Booster Vaccine in Children Aged Two to Five Years	No drug interventions	Not Available	Not Available	completed
NCT01917357	A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject	No drug interventions	prevention	3	completed